Activin and Inhibin

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 ( RIP2 ) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.In VitroGSK2983559 active

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 ( RIP2 ) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.In VitroGSK2983559 active

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 ( RIP2 ) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.In VitroGSK2983559 active

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 ( RIP2 ) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.In VitroGSK2983559 active

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 ( RIP2 ) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.In VitroGSK2983559 active

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 ( RIP2 ) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.In VitroGSK2983559 active

GSK321 is a potent inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) enzymes . GSK321 has high inhibitory and selectivity for mutant IDH1 enzymes. GSK321 can be used for the research of acute myeloid leukemiaIn VitroGSK321 has high inhibitory

GSK321 is a potent inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) enzymes . GSK321 has high inhibitory and selectivity for mutant IDH1 enzymes. GSK321 can be used for the research of acute myeloid leukemiaIn VitroGSK321 has high inhibitory

GSK321 is a potent inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) enzymes . GSK321 has high inhibitory and selectivity for mutant IDH1 enzymes. GSK321 can be used for the research of acute myeloid leukemiaIn VitroGSK321 has high inhibitory

GSK321 is a potent inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) enzymes . GSK321 has high inhibitory and selectivity for mutant IDH1 enzymes. GSK321 can be used for the research of acute myeloid leukemiaIn VitroGSK321 has high inhibitory

GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor ( IC 50 =3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM

GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor ( IC 50 =3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM